Evidence map›Paper›PMID 22023022›Full record

Trial reportPsychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors2012

Prospective analysis of early lapse to drinking and smoking among individuals in concurrent alcohol and tobacco treatment.

Laura J Holt, Mark D Litt, Ned L Cooney

Registry-linked trialAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00064844 (Combination Nicotine Replacement for Alcoholic Smokers), which is not on this map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00064844 phase4completednot on this map

Combination Nicotine Replacement for Alcoholic Smokers

TypeinterventionalSponsorYale UniversityRan2002 to 2006Enrolled96ConditionsSmoking, AlcoholismArmsCognitive Behavior Therapy for alcohol and smoking cessation, Nicoderm CQ nicotine patch, Placebo gum, Nicotine gum - Nicorette®
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. A systematic review of the relationships between craving and smoking cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Pooled it
  4. Using Elastic Net Penalized Cox Proportional Hazards Regression to Identify Predictors of Imminent Smoking Lapse.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Trial
  5. Within-person associations between daily motivation and self-efficacy and drinking among problem drinkers in treatment.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2016
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Smoking As an Outcome Moderator In the Treatment of Alcohol Use Disorders.Alcohol and alcoholism (Oxford, Oxfordshire) · 2022
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. [Effect of clinical characteristics on relapse of alcohol dependence: a prospective cohort study].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2019
    Article
  17. Assessment of Alcohol Use in the Natural Environment.Alcoholism, clinical and experimental research · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura J HoltDepartment of Psychology, Trinity College, Hartford, CT 06106, USA. laura.holt@trincoll.edu
Mark D Litt
Ned L Cooney

Funding

FIELD STUDY OF SMOKING CESSATION IN ALCOHOLISM TREATMENTR01AA011197 · NIAAA · YALE UNIVERSITY · PI COONEY, NED L · 1997 to 2011
$4.3M
NIAAA NIH HHS R01 AA011197
6 · The paper itself

Abstract

The aims of the current study were to examine, prospectively, (a) dynamic changes in affective state, self-efficacy, and urge in the hours before initial smoking and drinking lapses among individuals in concurrent alcohol and smoking treatment, and (b) the extent to which self-efficacy, urge to use, and/or the use of one substance predicted lapse to the other substance. Ninety-six men and women recruited for a clinical trial of concurrent alcohol and tobacco treatment were eligible for inclusion. Only data from those who experienced an initial lapse to drinking (n=29) or smoking (n=32) were included. Two outpatient substance abuse clinics provided concurrent alcohol and smoking treatment on a weekly basis for three months. Ecological Momentary Assessment (EMA) methods were employed over a 28-day monitoring period to assess antecedents to first drink, and a 14-day monitoring period was examined for initial smoking lapses. Baseline and EMA measures of positive and negative affect, alcohol/smoking urge, alcohol/smoking abstinence self-efficacy, nicotine withdrawal, and quantity/frequency of alcohol and tobacco use were examined as lapse predictors. Analyses of EMA ratings controlled for the corresponding baseline measure. Smoking lapse among individuals in concurrent alcohol and tobacco treatment was foreshadowed by higher urges to smoke, lower positive mood, and lower confidence to resist smoking. Drinking lapse was preceded by lower confidence to resist smoking, but only among individuals who reported recent smoking. Concurrent alcohol and smoking treatment should focus on the enhancement of abstinence self-efficacy, positive mood, and the curbing of urges in order to offset lapse risk.

Indexed as

AdultAlcoholismAmbulatory CareCognitive Behavioral TherapyCombined Modality TherapyComorbidityCuesFemaleHumansMaleMiddle AgedProspective StudiesRecurrenceSelf EfficacySmokingSmoking Cessation

Identifiers

PMID22023022
PMCPMC3336035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.